| abstract |
The invention provides a compound having the structure of formula I, a preparation method thereof, and use for treating cancer. The compound of the present invention has an inhibitory effect on a variety of cancer cells, and can be biologically transformed into the active drug Linifanib in vitro (in plasma), and can inhibit the proliferation of tumor cells, especially liver cancer cells, at a lower dose. |